Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 204
Ph III recruiting: 21
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 301–350 of 1,198 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05036681	A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma	terminated	Phase 2	9	M.D. Anderson Cancer CenterOTHER	1	Mar 27, 2026	clinicaltrials
NCT05142033	Avera Cancer Sequencing and Analytics Protocol (ASAP)(ASAP)	recruiting	—	25,000	Avera McKennan Hospital & University Health CenterOTHER	1	Mar 27, 2026